Milestone Pharmaceuticals' stock drops over 61% after receiving a Complete Response Letter from the FDA for its CARDAMYST NDA ...

Milestone Pharmaceuticals faces an FDA setback for its PSVT nasal spray. The company coordinates with regulatory authorities to resolve CRL issues.

CRL focused on CMC; no clinical issues relating to etripamil raised $69.7M in cash, cash equivalents and short-term investments as of December 31, 2024 MONTREAL and CHARLOTTE, N.C., March 28, 2025 ...

Milestone Pharmaceuticals (MIST) announced the U.S. Food and Drug Administration, FDA, issued a Complete Response Letter, CRL, regarding its ...

The issue came to light after forest officials transported the canoes via the second ghat road and conducted an inspection at Papavinasanam Dam, a crucial water source for the region. The department ...

The Food and Drug Administration (FDA) has issued a Complete Response Letter to Milestone Pharmaceuticals regarding the New Drug Application (NDA) for ...

CRL focused on CMC; no clinical issues relating to etripamil raised $69.7M in cash, cash equivalents and short-term investments as of December 31, 2024 MONTREAL and CHARLOTTE, N.C., March 28, 2025 ...

NBC 5 Responds is looking into your rights as an airline passenger after a French scientist was denied entry into the United ...

Specialists at the UK Sellafield site working with Canada’s AtkinsRéalis have successfully operated a robot remotely from an ...

Andhra Pradesh CM Naidu stresses the importance of the Polavaram project, ensures compensation for displaced families, and ...